Multiple sclerosis

被引:234
作者
Hafler, DA
Slavik, JM
Anderson, DE
O'Connor, KC
De Jager, P
Baecher-Allan, C
机构
[1] Harvard Univ, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Ctr Neurol Dis, Lab Mol Immunol, Boston, MA 02115 USA
[3] MIT, Broad Inst, Cambridge, MA 02139 USA
[4] Harvard Univ, Cambridge, MA 02138 USA
关键词
D O I
10.1111/j.0105-2896.2005.00240.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Multiple sclerosis (MS) is a complex genetic disease associated with inflammation in the central nervous system (CNS) white matter and is thought to be mediated by autoimmune processes. Clonal expansion of B cells, their antibody products, and T cells, hallmarks of inflammation in the CNS, are found in MS. The association of the disease with major histocompatibility complex genes, the inflammatory white matter infiltrates, similarities with animal models, and the observation that MS can be treated with immunomodulatory and immunosuppressive therapies support the hypothesis that autoimmunity plays a major role in the disease pathology. This review discusses the immunopathology of MS with particular focus given to regulatory T cells and the role of B cells and antibodies, immunomodulatory therapeutics, and finally new directions in MS research, particularly new methods to define the molecular pathology of human disease with high-throughput examination of germline DNA haplotypes, RNA expression, and protein structures that will allow the generation of a new series of hypotheses that can be tested to develop better understandings and therapies for this disease.
引用
收藏
页码:208 / 231
页数:24
相关论文
共 211 条
[1]   The impact of genotyping error on family-based analysis of quantitative traits [J].
Abecasis, GR ;
Cherny, SS ;
Cardon, LR .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2001, 9 (02) :130-134
[2]  
ADAMS JM, 1962, P SOC EXP BIOL MED, V111, P562, DOI 10.3181/00379727-111-27855
[3]   ASSOCIATION OF SUSCEPTIBILITY TO MULTIPLE-SCLEROSIS IN SWEDEN WITH HLA CLASS-II DRB1 AND DQB1 ALLELES [J].
ALLEN, M ;
SANDBERGWOLLHEIM, M ;
SJOGREN, K ;
ERLICH, HA ;
PETTERSON, U ;
GYLLENSTEN, U .
HUMAN IMMUNOLOGY, 1994, 39 (01) :41-48
[4]   Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes [J].
Aloisi, F ;
Ria, F ;
Adorini, L .
IMMUNOLOGY TODAY, 2000, 21 (03) :141-147
[5]  
Aloisi F, 1997, J IMMUNOL, V159, P1604
[6]   The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes [J].
Altshuler, D ;
Hirschhorn, JN ;
Klannemark, M ;
Lindgren, CM ;
Vohl, MC ;
Nemesh, J ;
Lane, CR ;
Schaffner, SF ;
Bolk, S ;
Brewer, C ;
Tuomi, T ;
Gaudet, D ;
Hudson, TJ ;
Daly, M ;
Groop, L ;
Lander, ES .
NATURE GENETICS, 2000, 26 (01) :76-80
[7]  
Ausubel LJ, 1997, J IMMUNOL, V159, P2502
[8]   Cross-reactivity of T-cell clones specific for altered peptide ligands of myelin basic protein [J].
Ausubel, LJ ;
Bieganowska, KD ;
Hafler, DA .
CELLULAR IMMUNOLOGY, 1999, 193 (01) :99-107
[9]   Complementary mutations in an antigenic peptide allow for crossreactivity of autoreactive T-cell clones [J].
Ausubel, LJ ;
Kwan, CK ;
Sette, A ;
Kuchroo, V ;
Hafler, DA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (26) :15317-15322
[10]   Early glial responses in murine models of multiple sclerosis [J].
Ayers, MM ;
Hazelwood, LJ ;
Catmull, DV ;
Wang, DW ;
McKormack, Q ;
Bernard, CCA ;
Orian, JM .
NEUROCHEMISTRY INTERNATIONAL, 2004, 45 (2-3) :409-419